Novo Nordisk A/S (NVO)
39.07
+0.57
(+1.48%)
USD |
NYSE |
Mar 05, 16:00
38.45
-0.62
(-1.59%)
Pre-Market: 08:51
Novo Nordisk Cash from Investing (TTM) : -12.02B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Ascendis Pharma A/S | -9.612M |
| Evaxion AS | -- |
| Regeneron Pharmaceuticals, Inc. | -629.10M |
| Viking Therapeutics, Inc. | 341.39M |
| DBV Technologies SA | 0.1363M |